Biocryst Pharmaceuticals Inc (BCRX)

Operating Cash Flow (Statement)

$104.34M

Quarterly · Period ending: · USD

BCRX logo

BCRX Operating Cash Flow (Statement)

Latest reported$104.34M
BCRX Quarterly Cash from Operations (-$1.70M → $104.34M)
High-resolution chart · PNG

BCRX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
104,342,000
-62,136,000
276,036,000
41,624,000
41,302,000
-27,517,000
-5,213,000
8,245,000
-1,368,000
-53,684,000
-8,918,000
-19,897,000
-18,814,000
-47,512,000
-23,849,000
-32,444,000
-27,757,000
-77,800,000
-32,459,000
-23,276,000
-25,411,000
-61,011,000
-44,639,000
-38,255,000
-31,041,000
-23,281,000
-10,448,000
-27,637,000
-24,501,000
-26,998,000
-23,985,000
-35,032,000
-13,895,000
-19,653,000
-10,519,000
-12,430,000
-9,667,000
-8,527,000
-5,854,000
-17,558,000
-11,184,000
-18,842,000
-14,828,000
-12,660,000
18,098,000
-3,726,000
-13,890,000
-8,600,000
-7,102,000
-8,959,000
-4,515,000
-7,922,000
-2,895,000
-11,198,000
-7,030,000
-11,777,000
-6,342,000
-12,248,000
-3,984,000
-10,469,000
-3,471,000
-14,327,000
-5,819,221
-9,228,000
-8,319,000
-5,188,000
9,635,530
-5,126,000
-11,668,000
-9,060,000
-4,537,820
-5,920,000
-5,915,000
-4,501,000
-16,004,799
-4,741,000
-855,000
-3,397,000
-14,876,315
-13,011,000
-13,671,000
26,347,000
-5,753,157
-6,141,000
-5,915,000
-5,537,000
-5,416,335
-3,864,000
-4,652,000
-4,219,000
-2,706,000
-3,028,000
-2,805,000
-2,657,000
-2,250,055
-3,363,000
-4,710,000
-6,041,000
-3,280,486
-2,183,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.